- Home
- ALAR vs ATNM Comparison
ALAR vs ATNM Comparison
Compare ALAR & ATNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALAR
- ATNM
- Stock Information
- Founded
- ALAR 2013
- ATNM 2000
- Country
- ALAR Israel
- ATNM United States
- Employees
- ALAR N/A
- ATNM N/A
- Industry
- ALAR Computer Software: Prepackaged Software
- ATNM Biotechnology: Pharmaceutical Preparations
- Sector
- ALAR Technology
- ATNM Health Care
- Exchange
- ALAR Nasdaq
- ATNM Nasdaq
- Market Cap
- ALAR 45.3M
- ATNM 51.5M
- IPO Year
- ALAR 2018
- ATNM N/A
- Fundamental
- Price
- ALAR $6.76
- ATNM $1.54
- Analyst Decision
- ALAR Strong Buy
- ATNM Strong Buy
- Analyst Count
- ALAR 1
- ATNM 3
- Target Price
- ALAR $11.00
- ATNM $4.67
- AVG Volume (30 Days)
- ALAR 130.2K
- ATNM 229.8K
- Earning Date
- ALAR 05-29-2025
- ATNM 05-09-2025
- Dividend Yield
- ALAR N/A
- ATNM N/A
- EPS Growth
- ALAR N/A
- ATNM N/A
- EPS
- ALAR 0.07
- ATNM N/A
- Revenue
- ALAR $30,581,000.00
- ATNM N/A
- Revenue This Year
- ALAR N/A
- ATNM N/A
- Revenue Next Year
- ALAR $12.28
- ATNM N/A
- P/E Ratio
- ALAR $11.37
- ATNM N/A
- Revenue Growth
- ALAR 4.67
- ATNM N/A
- 52 Week Low
- ALAR $5.45
- ATNM $1.03
- 52 Week High
- ALAR $46.69
- ATNM $8.64
- Technical
- Relative Strength Index (RSI)
- ALAR 41.20
- ATNM 49.81
- Support Level
- ALAR $7.42
- ATNM $1.56
- Resistance Level
- ALAR $8.57
- ATNM $1.69
- Average True Range (ATR)
- ALAR 0.65
- ATNM 0.11
- MACD
- ALAR -0.08
- ATNM -0.01
- Stochastic Oscillator
- ALAR 9.01
- ATNM 32.18
About ALAR Alarum Technologies Ltd.
Alarum Technologies Ltd is a software-as-a-service (SaaS) provider operating mainly in the web data collection market, offering web data collection and a private internet browsing platform. The company's Web Data Collection products offer secure, fast, and anonymous IP Proxy Network Solutions & Services, or IPPN or IPPN Solutions, to its business customers which, in turn, enables them to anonymously and securely browse the internet as well as to collect data from any publicly available source on the web, for their business purpose. The company operates in one segment, which is web data collection. Geographically, it derives maximum revenue from United Arab Emirates, followed by China, the United States, Europe, Asia-Pacific, U.K. Virgin Islands, Middle East and Africa, and other regions.
About ATNM Actinium Pharmaceuticals Inc. (Delaware)
Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of radiotherapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest to kill those cells safely and effectively. Its product candidates are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications, and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.